Phase II open-label study investigating apalutamide in patients with biochemical progression after radical prostatectomy.
Dirix P, Strijbos M, den Mooter TV, Liefhooghe N, Bruwaene SV, Uvin P, Ghysel C, Ost D, Schatteman P, Bral S, Engels B, den Begin RV, Otte FX, Roumeguere T, Palumbo S, Neybuch Y, Fonteyne V, Ost P, Dirix L.
Dirix P, et al. Among authors: palumbo s.
Future Oncol. 2020 Jun;16(16):1083-1189. doi: 10.2217/fon-2020-0056. Epub 2020 May 1.
Future Oncol. 2020.
PMID: 32356465